Herbalife Ltd.
12.63USD
+0.2000 (+1.61%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 5.2B | 5.1B | 5.0B | 5.0B | 5.3B | 5.4B |
| Q1 | 1.3B | 1.3B | 1.3B | 1.2B | 1.3B | — |
| Q2 | 1.4B | 1.3B | 1.3B | 1.3B | 1.3B | — |
| Q3 | 1.3B | 1.3B | 1.2B | 1.3B | 1.3B | — |
| Q4 | 1.2B* | 1.2B* | 1.2B* | 1.3B* | 1.3B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 3.23 | 1.42 | 2.50 | 2.20 | 2.37 | 3.08 |
| Q1 | .960 | .290 | .240 | .490 | .570 | — |
| Q2 | .880 | .600 | .050 | .480 | -.250 | — |
| Q3 | .830 | .430 | .460 | .420 | .617 | — |
| Q4 | .547* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| .102* |
| 1.75* |
| .824* |
| .609 |
| — |